BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.2466.67%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -122.00K | -114.40K | -130.80K | -114.40K | -113.60K |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -- | -- | -- | -- | -- |
Change in Net Operating Assets | 106.60K | 101.00K | 113.20K | 107.30K | 105.70K |
Cash from Operations | -15.40K | -13.40K | -17.60K | -7.10K | -7.90K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | 8.40K | 13.30K | 17.60K | 7.00K | 7.90K |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 8.00K | 100.00 | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 16.40K | 13.40K | 17.60K | 7.00K | 7.90K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 |